AlphaYouDH
Insider selling
David Happel sold $497K of Sagimet Biosciences Inc. (SGMT) stock
David Happel, President & CEO of Sagimet Biosciences Inc. (SGMT), sold 64,051 shares of SGMT stock worth $497K, per an SEC Form 4 filed Jul 22, 2026.
It was an open-market sale.
The trade happened on Jul 20, 2026, 2 days before it was made public.
SGMT has moved +50.8% since the trade date, from $7.16 to $10.80 (Sep 21, 2026 close).
- Traded
- Jul 20, 2026
- Disclosed
- Jul 22, 2026
- Filing delay
- 2 days
- Price since
- +50.8%
- Role
- President & CEO
- Source
- SEC Form 4
More SGMT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.